363 related articles for article (PubMed ID: 26848041)
1. Nanoparticle formulations of cisplatin for cancer therapy.
Duan X; He C; Kron SJ; Lin W
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):776-91. PubMed ID: 26848041
[TBL] [Abstract][Full Text] [Related]
2. Virus-based nanoparticles as platform technologies for modern vaccines.
Lee KL; Twyman RM; Fiering S; Steinmetz NF
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):554-78. PubMed ID: 26782096
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional platinum-based nanoparticles for biomedical applications.
Cheng Q; Liu Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27094725
[TBL] [Abstract][Full Text] [Related]
4. Modifying the tumor microenvironment using nanoparticle therapeutics.
Roy A; Li SD
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):891-908. PubMed ID: 27038329
[TBL] [Abstract][Full Text] [Related]
5. Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.
Lim YH; Tiemann KM; Hunstad DA; Elsabahy M; Wooley KL
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):842-871. PubMed ID: 27016134
[TBL] [Abstract][Full Text] [Related]
6. Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
Curtis C; Zhang M; Liao R; Wood T; Nance E
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27562224
[TBL] [Abstract][Full Text] [Related]
7. Targeted nanoparticles for head and neck cancers: overview and perspectives.
Zhao Y; Chen H; Chen X; Hollett G; Gu Z; Wu J; Liu X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28387452
[TBL] [Abstract][Full Text] [Related]
8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine approaches to improve cancer immunotherapy.
Qiu H; Min Y; Rodgers Z; Zhang L; Wang AZ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28296286
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional nanoparticle composites: progress in the use of soft and hard nanoparticles for drug delivery and imaging.
Sangtani A; Nag OK; Field LD; Breger JC; Delehanty JB
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28299903
[TBL] [Abstract][Full Text] [Related]
11. Advances in the development of aptamer drug conjugates for targeted drug delivery.
Chen K; Liu B; Yu B; Zhong W; Lu Y; Zhang J; Liao J; Liu J; Pu Y; Qiu L; Zhang L; Liu H; Tan W
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 27800663
[TBL] [Abstract][Full Text] [Related]
12. Use of nanoparticles to deliver immunomodulatory oligonucleotides.
Klinman DM; Sato T; Shimosato T
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):631-7. PubMed ID: 26663867
[TBL] [Abstract][Full Text] [Related]
13. Targeted nanomedicine in cisplatin-based cancer therapeutics.
Han Y; Wen P; Li J; Kataoka K
J Control Release; 2022 May; 345():709-720. PubMed ID: 35367476
[TBL] [Abstract][Full Text] [Related]
14. Challenges in preclinical to clinical translation for anticancer carrier-mediated agents.
Lucas AT; Madden AJ; Zamboni WC
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):642-53. PubMed ID: 26846457
[TBL] [Abstract][Full Text] [Related]
15. Design considerations for nanotherapeutics in oncology.
Stylianopoulos T; Jain RK
Nanomedicine; 2015 Nov; 11(8):1893-907. PubMed ID: 26282377
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview.
Farooq MA; Aquib M; Farooq A; Haleem Khan D; Joelle Maviah MB; Sied Filli M; Kesse S; Boakye-Yiadom KO; Mavlyanova R; Parveen A; Wang B
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1674-1692. PubMed ID: 31066300
[TBL] [Abstract][Full Text] [Related]
17. Peptide nanostructures in biomedical technology.
Feyzizarnagh H; Yoon DY; Goltz M; Kim DS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):730-43. PubMed ID: 26846352
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.
Colby AH; Oberlies NH; Pearce CJ; Herrera VL; Colson YL; Grinstaff MW
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 28185434
[TBL] [Abstract][Full Text] [Related]
19. Label-free detection and manipulation of single biological nanoparticles.
DeSantis MC; Cheng W
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):717-29. PubMed ID: 26846164
[TBL] [Abstract][Full Text] [Related]
20. Anti-platelet agents augment cisplatin nanoparticle cytotoxicity by enhancing tumor vasculature permeability and drug delivery.
Pandey A; Sarangi S; Chien K; Sengupta P; Papa AL; Basu S; Sengupta S
Nanotechnology; 2014 Nov; 25(44):445101. PubMed ID: 25302488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
